BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14642797)

  • 1. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.
    Ibáñez de Cáceres I; Priego T; Martín AI; Granado M; López-Calderón A; Villanúa MA
    Eur J Pharmacol; 2003 Nov; 481(2-3):293-9. PubMed ID: 14642797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression.
    Ibáñez de Cáceres I; Priego T; Martín AI; López-Calderón A; Villanúa MA
    J Neuroendocrinol; 2003 Dec; 15(12):1178-84. PubMed ID: 14636180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
    Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity.
    Ibáñez De Cáceres I; Holly JM; Priego T; Martín AI; López-Calderón A; Villanúa MA
    J Endocrinol; 2002 May; 173(2):357-64. PubMed ID: 12010643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of nitric oxide synthesis in inflammation. Relationship to oxygen-derived free radicals and prostaglandin synthesis.
    Gad MZ; Khattab M
    Arzneimittelforschung; 2000 May; 50(5):449-55. PubMed ID: 10858872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neuronal nitric oxide involved in adjuvant-induced joint inflammation?
    Pozza M; Bettelli C; Magnani F; Mascia MT; Manzini E; Calzà L
    Eur J Pharmacol; 1998 Oct; 359(1):87-93. PubMed ID: 9831298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats.
    Kato S; Ohkawa F; Ito Y; Amagase K; Takeuchi K
    J Physiol Pharmacol; 2009 Dec; 60(4):147-55. PubMed ID: 20065509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.
    Connor JR; Manning PT; Settle SL; Moore WM; Jerome GM; Webber RK; Tjoeng FS; Currie MG
    Eur J Pharmacol; 1995 Jan; 273(1-2):15-24. PubMed ID: 7537678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis.
    Tanaka S; Matsui T; Murakami T; Ishizuka T; Sugiura M; Kawashima K; Sugita T
    Int J Immunopharmacol; 1998; 20(1-3):71-84. PubMed ID: 9717083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.
    Sugita H; Kaneki M; Tokunaga E; Sugita M; Koike C; Yasuhara S; Tompkins RG; Martyn JA
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E386-94. PubMed ID: 11788371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats.
    Yonekura Y; Koshiishi I; Yamada K; Mori A; Uchida S; Nakamura T; Utsumi H
    Nitric Oxide; 2003 May; 8(3):164-9. PubMed ID: 12826065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats.
    Wada K; Chatzipanteli K; Kraydieh S; Busto R; Dietrich WD
    Neurosurgery; 1998 Dec; 43(6):1427-36. PubMed ID: 9848857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis.
    Cuzzocrea S; Chatterjee PK; Mazzon E; McDonald MC; Dugo L; Di Paola R; Serraino I; Britti D; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2002 Oct; 453(1):119-29. PubMed ID: 12393067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ultrasound and diclofenac phonophoresis on inflammatory pain relief: suppression of inducible nitric oxide synthase in arthritic rats.
    Hsieh YL
    Phys Ther; 2006 Jan; 86(1):39-49. PubMed ID: 16386061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
    Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
    J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment.
    Chatzipanteli K; Garcia R; Marcillo AE; Loor KE; Kraydieh S; Dietrich WD
    J Neurotrauma; 2002 May; 19(5):639-51. PubMed ID: 12042098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic and acute aminoguanidine treatment on tail artery vasomotion in ageing rats.
    Tabernero A; Nadaud S; Corman B; Atkinson J; Capdeville-Atkinson C
    Br J Pharmacol; 2000 Nov; 131(6):1227-35. PubMed ID: 11082132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
    Wang D; Yang XP; Liu YH; Carretero OA; LaPointe MC
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):174-82. PubMed ID: 10090345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.